5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
5-Azacytidine modulates CpG methylation levels of EZH2 and NOTCH1 in myelodysplastic syndromes
Authors
Keywords
5-Azacytidine, Azacitidine, Myelodysplastic syndromes, CpG methylation, EZH2, NOTCH1
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-09-10
DOI
10.1007/s00432-019-03016-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ensembl 2018
- (2017) Daniel R Zerbino et al. NUCLEIC ACIDS RESEARCH
- Prediction of genome-wide DNA methylation in repetitive elements
- (2017) Yinan Zheng et al. NUCLEIC ACIDS RESEARCH
- EZH2 mutations and promoter hypermethylation in childhood acute lymphoblastic leukemia
- (2016) Vivien Schäfer et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Mutation allele burden remains unchanged in chronic myelomonocytic leukaemia responding to hypomethylating agents
- (2016) Jane Merlevede et al. Nature Communications
- Gene-set Analysis with CGI Information for Differential DNA Methylation Profiling
- (2016) Chia-Wei Chang et al. Scientific Reports
- Digging deep into “dirty” drugs – modulation of the methylation machinery
- (2015) Lisa Pleyer et al. DRUG METABOLISM REVIEWS
- On the presence and role of human gene-body DNA methylation
- (2015) Daudi Jjingo et al. Oncotarget
- LINE-1 Hypomethylation in Blood and Tissue Samples as an Epigenetic Marker for Cancer Risk: A Systematic Review and Meta-Analysis
- (2014) Martina Barchitta et al. PLoS One
- Genotyping of 25 Leukemia-Associated Genes in a Single Work Flow by Next-Generation Sequencing Technology with Low Amounts of Input Template DNA
- (2013) J. Rinke et al. CLINICAL CHEMISTRY
- Dynamic transcriptomes of human myeloid leukemia cells
- (2013) Hai Wang et al. GENOMICS
- Predictive factors of response and survival among chronic myelomonocytic leukemia patients treated with azacitidine
- (2013) Lionel Adès et al. LEUKEMIA RESEARCH
- Modification of Enhancer Chromatin: What, How, and Why?
- (2013) Eliezer Calo et al. MOLECULAR CELL
- Tobacco Smoking Leads to Extensive Genome-Wide Changes in DNA Methylation
- (2013) Sonja Zeilinger et al. PLoS One
- DNA methylation data analysis and its application to cancer research
- (2013) Xiaotu Ma et al. Epigenomics
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- CpG islands and the regulation of transcription
- (2011) A. M. Deaton et al. GENES & DEVELOPMENT
- Conserved role of intragenic DNA methylation in regulating alternative promoters
- (2010) Alika K. Maunakea et al. NATURE
- A Comparison of Azacitidine and Decitabine Activities in Acute Myeloid Leukemia Cell Lines
- (2010) Paul W. Hollenbach et al. PLoS One
- CpG islands - ‘A rough guide’
- (2009) Robert S. Illingworth et al. FEBS LETTERS
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Review of azacitidine trials in Intermediate-2-and High-risk myelodysplastic syndromes
- (2009) Pierre Fenaux et al. LEUKEMIA RESEARCH
- High-throughput sequence-based epigenomic analysis of Alu repeats in human cerebellum
- (2009) Hehuang Xie et al. NUCLEIC ACIDS RESEARCH
- Azacytidine causes complex DNA methylation responses in myeloid leukemia
- (2008) C. Stresemann et al. MOLECULAR CANCER THERAPEUTICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started